Provided by Tiger Fintech (Singapore) Pte. Ltd.

LakeShore Biopharma Co., Ltd.

0.8215
+0.02142.67%
Volume:21.08K
Turnover:17.61K
Market Cap:33.86M
PE:-0.15
High:0.8500
Open:0.8500
Low:0.8020
Close:0.8001
52wk High:8.60
52wk Low:0.5900
Shares:41.21M
Float Shares:25.73M
Volume Ratio:0.40
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.6146
EPS(LYR):-5.6146
ROE:-18.43%
ROA:-2.15%
PB:0.48
PE(LYR):-0.15

Loading ...

Company Profile

Company Name:
LakeShore Biopharma Co., Ltd.
Exchange:
NASDAQ
Establishment Date:
1994
Employees:
573
Office Location:
Building No. 2,38 Yongda Road,Daxing Biomedical Industry Park,Daxing District,Beijing,China
Zip Code:
102629
Fax:
- -
Introduction:
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

Directors

Name
Position
Hui Shao
Director, President, Chief Business Officer and Vice Chairman of the Board
Xu Wang
Director and Chief Executive Officer
Pierson Yue Pan
Director and Chairperson of the Board
Rachel Yu
Director and Chief Financial Officer
Adam Zhao
Director
Chunyang Shao
Director
Thomas Xue
Director

Shareholders

Name
Position
Xu Wang
Director and Chief Executive Officer
Rachel Yu
Director and Chief Financial Officer
Honggang Teng
Head of Production and Quality Management
Hui Shao
Director, President, Chief Business Officer and Vice Chairman of the Board
Yuan Liu
Head of Vaccine Research
Zhiyuan Ran
Head of Marketing and Sales